Nutracêuticos em enxaqueca crônica: vale a pena?
DOI:
https://doi.org/10.34119/bjhrv7n4-132Keywords:
nutracêutico, dor de cabeça, enxaquecaAbstract
A enxaqueca crônica ocorre em 3% da população, sendo caracterizada por ataques recorrentes de cefaleia, de caráter pulsátil, localização unilateral, intensidade moderada e forte, que piora com atividades físicas rotineiras e pode ser acompanhada de náuseas e/ou vômitos ou fonofobia e fotofobia. O diagnóstico é essencialmente clínico e deve obedecer aos critérios da International Classification of Headache Disorders de 2018 (ICHD-3). Além das opções terapêuticas já consolidadas, estudos mostram que o uso de nutracêuticos - alimentos, componentes de alimentos ou suplementos nutricionais que atuam na prevenção e tratamento de doenças - podem ser uma terapia alternativa eficiente na enxaqueca. Substâncias nutracêuticas demonstram potenciais resultados benéficos no tratamento de diversas condições, inclusive da enxaqueca crônica, com a vantagem de possuírem bom perfil de efeitos adversos, além de baixo custo.
References
AHMADI, H. et al. Zinc supplementation affects favorably the frequency of migraine attacks: a double-blind randomized placebo-controlled clinical trial. Nutrition Journal, v. 19, n. 1, p. 101, dez. 2020.
BABAPOUR, M. et al. Effect of soy isoflavones supplementation on migraine characteristics, mental status and calcitonin gene-related peptide (CGRP) levels in women with migraine: results of randomised controlled trial. Nutrition Journal, v. 21, n. 1, p. 50, dez. 2022.
CAETANO, Marcos Pereira; NIELSON, Sylvia Escher De Oliveira; MACEDO, Isaac Yves Lopes De; et al. Comercialização, dispensação e prescrição de Nutracêuticos antioxidantes por farmacêuticos: Marketing, dispensing and prescription of antioxidant Nutraceutics by pharmacists. Brazilian Journal of Health Review, v. 5, n. 5, p. 18045–18059, 2022. Disponível em: <https://brazilianjournals.com/ojs/index.php/BJHR/article/view/51780>. Acesso em: 14 jul. 2024.
CHALIHA, D. R. et al. A Paradoxical Vasodilatory Nutraceutical Intervention for Prevention and Attenuation of Migraine—A Hypothetical Review. Nutrients, v. 12, n. 8, p. 2487, 18 ago. 2020.
CHALIHA, D. R. et al. L-arginine and aged garlic extract for the prevention of migraine: a study protocol for a randomised, double-blind, placebo-controlled, phase-II trial (LARGE trial). BMC Neurology, v. 23, n. 1, p. 122, 27 mar. 2023.
CURATOLO, P.; MOAVERO, R. Use of Nutraceutical Ingredient Combinations in the Management of Tension-Type Headaches with or without Sleep Disorders. Nutrients, v. 13, n. 5, p. 1631, 13 maio 2021.
DELL’ISOLA, G. B. et al. The Vitamin D Role in Preventing Primary Headache in Adult and Pediatric Population. Journal of Clinical Medicine, v. 10, n. 24, p. 5983, 20 dez. 2021.
DZATOR, J. S. A. et al. A Randomised, Double-Blind, Placebo-Controlled Crossover Trial of Resveratrol Supplementation for Prophylaxis of Hormonal Migraine. Nutrients, v. 14, n. 9, p. 1763, 22 abr. 2022.
ESPARHAM, A. et al. Pediatric Headache Clinic Model: Implementation of Integrative Therapies in Practice. Children, v. 5, n. 6, p. 74, 12 jun. 2018.
GHORBANI, Z. et al. The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial. The Journal of Headache and Pain, v. 21, n. 1, p. 22, dez. 2020.
GRECH, O. et al. The Role of Metabolism in Migraine Pathophysiology and Susceptibility. Life, v. 11, n. 5, p. 415, 1 maio 2021.
GROSS, E. C. et al. The metabolic face of migraine — from pathophysiology to treatment. Nature Reviews Neurology, v. 15, n. 11, p. 627–643, nov. 2019.
HAGHDOOST, F.; TOGHA, M. Migraine management: Non-pharmacological points for patients and health care professionals. Open Medicine, v. 17, n. 1, p. 1869–1882, 23 nov. 2022.
KAUR, K. et al. The Efficacy of Herbal Supplements and Nutraceuticals for Prevention of Migraine: Can They Help? Cureus, 6 maio 2021.
KELISHADI, M. R. et al. The beneficial effect of Alpha-lipoic acid supplementation as a potential adjunct treatment in episodic migraines. Scientific Reports, v. 12, n. 1, p. 271, 7 jan. 2022.
LIAMPAS, I. N. et al. Pyridoxine, folate and cobalamin for migraine: A systematic review. Acta Neurologica Scandinavica, v. 142, n. 2, p. 108–120, ago. 2020.
LOH, N. R.; WHITEHOUSE, W. P.; HOWELLS, R. What is new in migraine management in children and young people? Archives of Disease in Childhood, v. 107, n. 12, p. 1067–1072, dez. 2022.
MAIER, J. A. et al. Headaches and Magnesium: Mechanisms, Bioavailability, Therapeutic Efficacy and Potential Advantage of Magnesium Pidolate. Nutrients, v. 12, n. 9, p. 2660, 31 ago. 2020.
MOSCANO, F. et al. An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache. Italian Journal of Pediatrics, v. 45, n. 1, p. 36, dez. 2019.
ON BEHALF OF THE SCHOOL OF ADVANCED STUDIES OF THE EUROPEAN HEADACHE FEDERATION (EHF-SAS) et al. Gut-brain Axis and migraine headache: a comprehensive review. The Journal of Headache and Pain, v. 21, n. 1, p. 15, dez. 2020.
ONOFRI, A.; NECOZIONE, S.; TOZZI, E. Complementary and alternative medicine (CAM) in headache of children and adolescents: open-label Italian study. LA CLINICA TERAPEUTICA, n. 5, p. 393–398, 10 set. 2020.
PAPETTI, L. et al. Truths and Myths in Pediatric Migraine and Nutrition. Nutrients, v. 13, n. 8, p. 2714, 6 ago. 2021.
PULEDDA, F.; SHIELDS, K. Non-Pharmacological Approaches for Migraine. Neurotherapeutics, v. 15, n. 2, p. 336–345, abr. 2018.
SAZALI, S. et al. Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine—a meta-analysis. BMJ Open, v. 11, n. 1, p. e039358, jan. 2021.
SEDIGHIYAN, M. et al. The effects of nano-curcumin supplementation on adipokines levels in obese and overweight patients with migraine: a double blind clinical trial study. BMC Research Notes, v. 15, n. 1, p. 189, dez. 2022.
SCUASSANTE, Bianca Castoldi; VIEIRA, Bruno Henrique; GRANZIERI, Isabela Abade; et al. Migrânea crônica - perspectivas atuais e desafios futuros. Brazilian Journal of Health Review, v. 7, n. 1, p. 4480–4487, 2024.
